Jeffrey Sturchio

President and CEO,
Global Health Council

Jeffrey Sturchio is president and CEO of the Global Health Council, the world’s largest membership alliance of public health organizations and professionals dedicated to saving lives by improving health throughout the world.

Dr. Sturchio recently retired from Merck, where he served as vice president for corporate responsibility and managed a portfolio of activities including Merck’s corporate philanthropy, global health partnerships, and global HIV/AIDS access programs. He also served as president of The Merck Company Foundation. Dr. Sturchio was centrally involved in Merck’s participation in the UN/Industry Accelerating Access Initiative to help improve HIV/AIDS care and treatment in the developing world. He was a member of the board of the African Comprehensive HIV/AIDS Partnerships in Botswana (2005-2009) and a member of the private sector delegation to the board of the Global Fund to Fight AIDS, TB and Malaria (2002-2008). From 2008-2009, Dr. Sturchio served as chairman of the Corporate Council on Africa, whose 180 member companies represent some 85 percent of total U.S. private sector investment in Africa and work closely with governments, multilateral organizations, NGOs and business to improve the trade and investment climate on the African continent.

Dr. Sturchio is widely published both in book and periodical form including an article entitled Business Engagement in Public Programs: The Pharmaceutical Industry’s Contribution to Public Health and the Millennium Development Goals that was published in the Journal Corporate Governance: The International Journal of Business in Society in 2008.

Dr. Sturchio received a BA in History from Princeton University and a PhD in the History and Sociology of Science from the University of Pennsylvania. He has been a postdoctoral fellow and senior fellow at the Smithsonian Institution’s National Museum of American History (NMAH) and a visiting fellow of LSE Health and Social Care at the London School of Economics. In 2004 he was elected a fellow of the American Association for the Advancement of Science.